亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。
Recombinant Human Follicle Stimulating Hormone Antagonists and Methods in Cancer Therapy
技術優勢
This antagonist is a competitive inhibitor of the FSH receptor.rFSH-Ant can be produced using standard molecular biology and recombinant protein technologies.May be administered by a variety of routes, including intravenously, orally, locally and transdermally.
技術應用
Therapy for cancers that secrete or respond to FSH, such as epithelial ovarian cancer. ContraceptiveTreatment for ovarian hyperstimulation syndrome (OHSS).
詳細技術說明
The present invention comprises of recombinant human follicle stimulating hormone antagonist (rFSH-Ant) in which one or more N-glycosylation sites is disrupted. rFSH-Ant binds to the FSH receptor without activating it, thereby acting as a competitive...
國家/地區
美國
欲了解更多信息，請點擊 這裡
